Pr Benjamin Besse
- Spécialité
- Oncologue médical, expert poumon
- Titre
- Directeur de la Recherche Clinique
- Hôpital
- Gustave Roussy (Villejuif)
- Derniers articles
-
- Benzodiazepines interfere with the efficacy of pembrolizumab-based cancer immunotherapy. Results of a nationwide cohort study including over 50,000 participants with advanced lung cancer. (1 déc. 2025)
- Lazertinib Versus Osimertinib in Previously Untreated EGFR-mutant Advanced NSCLC: A Randomized, Double-blind, Exploratory Analysis From MARIPOSA. (3 juil. 2025)
- Frequency of driver oncogenic alterations in NSCLC and estimated indoor radon exposure in Europe (RADON EUROPE study). (26 juin 2025)
- Morphine and metformin impact immunotherapy benefit in patients with NSCLC: Results of the real-world study IFCT-1502 CLINIVO-SNDS. (11 juin 2025)
- Surgical and Perioperative Advances for Patients With Locally Advanced Non-Small Cell Lung Cancer. (1 juin 2025)